For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain.
FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...
In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...
According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
ZME Science on MSN13d
Most Back Pain Treatments Don’t Work—Here’s What Actually HelpsNSAIDs also help with acute pain, but they should be used sparingly. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ...
Each year, millions of people in America are prescribed a medicine for acute pain.Now, for the first time in over 20 years, ...
More severe acute pain trajectories led to greater opioid consumption and longer hospitalization among older patients with fragility hip fractures.
The researchers reviewed 301 randomized, controlled trials that included data on 56 non-surgical treatments for adults ...
This case emphasises the need for early recognition and proper diagnosis of CHIKV infection in patients with acute joint pain ...
Continuing buprenorphine during acute pain episodes in patients with opioid use disorder (OUD) may lead to similar or improved pain outcomes compared to discontinuation, though overall evidence is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback